Upcoming event

The ERUS curriculum for robot-assisted partial nephrectomy: structure definition and pilot clinical validation

European Urology, Volume 75, Issue 6, June 2019, Pages 1023-1031

Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients

September 2019

First-line pembrolizumab (pembro) monotherapy for advanced non‒clear cell renal cell carcinoma (nccRCC): updated follow-up for keynote-427 cohort b

September 2019

Advanced clear-cell renal cell carcinoma (accRCC): association of microRNAs (miRNAs) with molecular subtypes, mRNA targets and outcome

September 2019

Quality of life in previously untreated patients with advanced renal cell carcinoma (aRCC) in CheckMate 214: updated results

, September 2019

Intensive imaging-based follow-up of surgically treated localised renal cell carcinoma does not improve post-recurrence survival: results from a European Multicentre Database (RECUR)

European Urology, Volume 75, Issue 2, February 2019, Pages 261-264

Tumour seeding in the tract of percutaneous renal tumour biopsy: a report on seven cases from a UK tertiary referral centre

European Urology, Volume 75, Issue 5, May 2019, Pages 861-867

Unraveling the molecular profile underpinning pancreatic tropisms in metastatic clear cell renal cell carcinoma

May 2019

Randomized, double-blind phase III study of pazopanib versus placebo in patients with metastatic renal cell carcinoma who have no evidence of disease following metastasectomy: A trial of the ECOG-ACRIN cancer research group (E2810)

May 2019

Cardiovascular mortality in renal cell carcinoma: A population-based study

May 2019

Stereotactic radiotherapy for stage I renal cell carcinoma: Overall survival and treatment trends compared to thermal ablation and surgical resection

May 2019

Testing the external validity of CARMENA trial comparing sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma

Next